Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ethypharm (Omeprazole and Ketoprofen products)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A portfolio of gastrointestinal problems treating product line. The product line consists of omeprazole (proton pump inhibitor) and ketoprofen (nonsteroidal anti-inflammatory drug) that come in the form of a capsule and offers protection against nonsteroidal anti-inflammatory drug's side effects and mucosal injuries.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
Primary Office
  • 194, Bureaux de la Colline
  • 92213 Saint-Cloud
  • France

Ethypharm (Omeprazole and Ketoprofen products) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Ethypharm (Omeprazole and Ketoprofen products)‘s full profile, request access.

Request full access to PitchBook